What is Chemed's deferred tax liabilities - deferred expense?

Chemed (CHE) reported deferred tax liabilities - deferred expense of $2.13M in Q4 2025.

How has Chemed's deferred tax liabilities - deferred expense changed year-over-year?

Chemed's deferred tax liabilities - deferred expense increased by 4.5% year-over-year, from $2.04M to $2.13M.

What is the long-term trend for Chemed's deferred tax liabilities - deferred expense?

Over 5 years (2020 to 2025), Chemed's deferred tax liabilities - deferred expense has grown at a 12.9% compound annual growth rate (CAGR), from $1.16M to $2.13M.

Chemed CHE Deferred Tax Liabilities - Deferred Expense

Deferred Tax Liabilities - Deferred Expense at other companies

Hilton WorldwideHLT

$278M-6.1%

Otis WorldwideOTIS

$221M+8.9%

PaychexPAYX

$553.5M+495%

Ionis PharmaceuticalsIONS

$7.15M+277%

Wintrust FinancialWTFC

$3.08M+15.6%

Old Republic InternationalORI

$210.6M+20.7%

Other financials

Income statement

See full

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Balance sheet

See full

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Cash flow

See full

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Valuation

See full

Market cap$5.79B-42.3%

Enterprise value$6.01B-39.6%

P/E22.3×-10.2×

P/S2.3×-1.8×

Profitability

See full

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Returns & leverage

See full

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxLiabilitiesDeferredExpense.

The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's deferred tax liabilities - deferred expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemed's deferred tax liabilities - deferred expense?: Chemed (CHE) reported deferred tax liabilities - deferred expense of $2.13M in Q4 2025.
How has Chemed's deferred tax liabilities - deferred expense changed year-over-year?: Chemed's deferred tax liabilities - deferred expense increased by 4.5% year-over-year, from $2.04M to $2.13M.
What is the long-term trend for Chemed's deferred tax liabilities - deferred expense?: Over 5 years (2020 to 2025), Chemed's deferred tax liabilities - deferred expense has grown at a 12.9% compound annual growth rate (CAGR), from $1.16M to $2.13M.